A Comparison of Immune Responses Exerted Following Syngeneic, Allogeneic, and Xenogeneic Transplantation of Mesenchymal Stem Cells into the Mouse Brain

被引:32
作者
Hwang, Jung Won [1 ,2 ]
Lee, Na Kyung [2 ,3 ,4 ]
Yang, Je Hoon [5 ]
Son, Hyo Jin [2 ,3 ,4 ,6 ]
Bang, Sa Ik [7 ]
Chang, Jong Wook [1 ,2 ,8 ]
Na, Duk L. [1 ,2 ,4 ,6 ,9 ]
机构
[1] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, 81 Irwon Ro, Seoul 06351, South Korea
[2] Samsung Med Ctr, Stem Cell & Regenerat Med Inst, 81 Irwon Ro, Seoul 06351, South Korea
[3] Sungkyunkwan Univ, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea
[4] Samsung Med Ctr, Samsung Alzheimer Res Ctr, 81 Irwon Ro, Seoul 06351, South Korea
[5] Samsung Biomed Res Inst, Lab Anim Res Ctr, 81 Irwon Ro, Seoul 06351, South Korea
[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Plast Surg, 81 Irwon Ro, Seoul 06351, South Korea
[8] ENCell Co Ltd, R&D Ctr, Seoul 06072, South Korea
[9] Samsung Med Ctr, Neurosci Ctr, 81 Irwon Ro, Seoul 06072, South Korea
关键词
mesenchymal stem cell; immunogenic; syngeneic; allogeneic; xenogeneic; MARROW STROMAL CELLS; EPIGENETICS; MECHANISMS; THERAPY; FATE; DISEASE; INNATE;
D O I
10.3390/ijms21093052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Due to their multifactorial aspects, mesenchymal stem cells (MSCs) have been widely established as an attractive and potential candidate for the treatment of a multitude of diseases. A substantial number of studies advocate that MSCs are poorly immunogenic. In several studies, however, immune responses were observed following injections of xenogeneic donor MSCs. In this study, the aim was to examine differences in immune responses exerted based on transplantations of xenogeneic, syngeneic, and allogeneic MSCs in the wild-type mouse brain. Xenogeneic, allogeneic, and syngeneic MSCs were intracerebrally injected into C57BL/6 mice. Mice were sacrificed one week following transplantation. Based on immunohistochemical (IHC) analysis, leukocytes and neutrophils were expressed at the injection sites in the following order (highest to lowest) xenogeneic, allogeneic, and syngeneic. In contrast, microglia and macrophages were expressed in the following order (highest to lowest): syngeneic, allogeneic, and xenogeneic. Residual human MSCs in the mouse brain were barely detected after seven days. Although the discrepancy between leukocytes versus macrophages/microglia infiltration should be resolved, our results overall argue against the previous notions that MSCs are poorly immunogenic and that modulation of immune responses is a prerequisite for preclinical and clinical studies in MSC therapy of central nervous system diseases.
引用
收藏
页数:17
相关论文
共 62 条
[1]   Unveiling the Role of DNA Methylation in Kidney Transplantation: Novel Perspectives toward Biomarker Identification [J].
Agodi, Antonella ;
Barchitta, Martina ;
Maugeri, Andrea ;
Basile, Guido ;
Zamboni, Matilde ;
Bernardini, Giulia ;
Corona, Daniela ;
Veroux, Massimiliano .
BIOMED RESEARCH INTERNATIONAL, 2019, 2019
[2]   Mesenchymal stem cells: immune evasive, not immune privileged [J].
Ankrum, James A. ;
Ong, Joon Faii ;
Karp, Jeffrey M. .
NATURE BIOTECHNOLOGY, 2014, 32 (03) :252-260
[3]   Differential cytokine contributions of perivascular haematopoietic stern cell niches [J].
Asada, Noboru ;
Kunisaki, Yuya ;
Pierce, Halley ;
Wang, Zichen ;
Fernandez, Nicolas F. ;
Birbrair, Alexander ;
Ma'ayan, Avi ;
Frenette, Paul S. .
NATURE CELL BIOLOGY, 2017, 19 (03) :214-223
[4]  
Atoui Rony, 2013, Methods Mol Biol, V1036, P107, DOI 10.1007/978-1-62703-511-8_10
[5]   Pericytes modulate myelination in the central nervous system [J].
Azevedo, Patrick O. ;
Sena, Isadora F. G. ;
Andreotti, Julia P. ;
Carvalho-Tavares, Juliana ;
Alves-Filho, Jose C. ;
Cunha, Thiago M. ;
Cunha, Fernando Q. ;
Mintz, Akiva ;
Birbrair, Alexander .
JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (08) :5523-5529
[6]   Cell Therapy for Parkinson's Disease: A Translational Approach to Assess the Role of Local and Systemic Immunosuppression [J].
Badin, R. Aron ;
Vadori, M. ;
Vanhove, B. ;
Nerriere-Daguin, V. ;
Naveilhan, P. ;
Neveu, I. ;
Jan, C. ;
Leveque, X. ;
Venturi, E. ;
Mermillod, P. ;
Van Camp, N. ;
Dolle, F. ;
Guillermier, M. ;
Denaro, L. ;
Manara, R. ;
Citton, V. ;
Simioni, P. ;
Zampieri, P. ;
D'avella, D. ;
Rubello, D. ;
Fante, F. ;
Boldrin, M. ;
De Benedictis, G. M. ;
Cavicchioli, L. ;
Sgarabotto, D. ;
Plebani, M. ;
Stefani, A. L. ;
Brachet, P. ;
Blancho, G. ;
Soulillou, J. P. ;
Hantraye, P. ;
Cozzi, E. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (07) :2016-2029
[7]  
Balabanov R, 1999, J NEUROSCI RES, V55, P578, DOI 10.1002/(SICI)1097-4547(19990301)55:5<578::AID-JNR5>3.0.CO
[8]  
2-E
[9]   Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells [J].
Berglund, Alix K. ;
Fortier, Lisa A. ;
Antczak, Douglas F. ;
Schnabel, Lauren V. .
STEM CELL RESEARCH & THERAPY, 2017, 8
[10]   Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression [J].
Candolfi, Marianela ;
Curtin, James F. ;
Nichols, W. Stephen ;
Muhammad, A. K. M. G. ;
King, Gwendalyn D. ;
Pluhar, G. Elizabeth ;
McNiel, Elizabeth A. ;
Ohlfest, John R. ;
Freese, Andrew B. ;
Moore, Peter F. ;
Lerner, Jonathan ;
Lowenstein, Pedro R. ;
Castro, Maria G. .
JOURNAL OF NEURO-ONCOLOGY, 2007, 85 (02) :133-148